J. L. Mondaza-Hernandez

A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons

J. Martín-Broto, J. L. Mondaza-Hernandez, D. Moura, 2021, Cancers.

Cancer Stem Cells in Soft-Tissue Sarcomas

J. Martín-Broto, A. Obrador-Hevia, J. L. Mondaza-Hernandez, 2020, Cells.

CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study

J. Martín-Broto, J. López-Guerrero, M. Tarón, 2020, Cancers.

ISG15 as a prognostic biomarker in solitary fibrous tumour

R. Maestro, J. Martín-Broto, J. García-Foncillas, 2022, Cellular and Molecular Life Sciences.

Expression of p53 as a biomarker of pazopanib efficacy in solitary fibrous tumours: translational analysis of a phase II trial

J. Martín-Broto, S. Stacchiotti, B. Vincenzi, 2022, Therapeutic advances in medical oncology.

A Novel NFIX-STAT6 Gene Fusion in Solitary Fibrous Tumor: A Case Report

F. Rojo, C. Fletcher, J. Martín-Broto, 2021, International journal of molecular sciences.

Efficacy of Eribulin Plus Gemcitabine Combination in L-Sarcomas

J. Martín-Broto, C. Castilla, J. L. Mondaza-Hernandez, 2022, International journal of molecular sciences.

Reduction of Tumor Growth with RNA-Targeting Treatment of the NAB2–STAT6 Fusion Transcript in Solitary Fibrous Tumor Models

J. Martín-Broto, L. Bleris, Yi Li, 2023, Cancers.

STAT6-targeting antisense oligonucleotides against solitary fibrous tumor

Heather N. Hayenga, J. Martín-Broto, L. Bleris, 2024, Molecular therapy. Nucleic acids.